Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-22

Clinical Trial Update: Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients [Phase 4]

View source ↗

Summary

A Phase 4 epidemiological study completed, evaluating the prevalence of the HLA-B*57:01 allele in HIV-1 infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED